A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

NCT01490866 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Axitinib
DRUG: Bevacizumab
DRUG: 5-Fluorouracil
DRUG: 5-Fluorouracil
DRUG: Leucovorin
DRUG: Oxaliplatin

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]